Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01433159 · ClinicalTrials.gov registry record · Phase 2
Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
A Phase 2 study, sponsored by Healthpoint.
- Terminated
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT01433159 is a Phase 2 study that was terminated before completion, run by Healthpoint. The registered enrollment target is 19 participants.
The verdict
NCT01433159, a Phase 2 study, was terminated before completion, sponsored by Healthpoint.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
The trial will compare the effects of 14 days treatment with HP011 101 versus Standard Care in subjects with Stage I or II pressure ulcers as a complication of spinal cord injury, measured as change from baseline in composite wound bed scores of the PUSH 3.0 tool.
Interventions
- DRUG Standard Care
- DRUG HP011-101 (Xenaderm Ointment)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01433159
The ClinicalTrials.gov registry entry for NCT01433159 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT01433159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01433159 about?
NCT01433159 is a clinical study titled "Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury". The trial will compare the effects of 14 days treatment with HP011 101 versus Standard Care in subjects with Stage I or II pressure ulcers as a complication of spinal cord injury, measured as change from baseline in composite wound bed scores of the PUSH 3.0 tool.
What is the current status of trial NCT01433159?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2011-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01433159?
The interventions under investigation include: Standard Care (DRUG), HP011-101 (Xenaderm Ointment) (DRUG).
Who is sponsoring clinical trial NCT01433159?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.